文献速递遗传性与小管间质肾病慢性肾脏病

JAG1单等位基因致病变异导致常染色体显性肾小管间质性肾病(ADTKD-JAG1)

Mono-allelic pathogenic variants in JAG1 cause autosomal dominant tubulo-interstitial kidney disease (ADTKD-JAG1).
PubMed 文献 · Kidney Int · 2025-10-06

研究在203个ADTKD家系及散发肾病和CKD5期病例中筛查JAG1变异,在三个未确诊ADTKD大家系中发现致病或可能致病变异,患者表现为孤立性肾小管间质性肾炎而无Alagille综合征表现,机制为单倍剂量不足而非蛋白毒性。

要点

  • JAG1致病变异可导致孤立性ADTKD,无Alagille综合征表现。
  • 对未确诊ADTKD家系应筛查JAG1基因。
  • JAG1变异所致肾病机制为单倍剂量不足和功能丧失。

核心结论

  • JAG1致病或可能致病变异可见于未确诊的ADTKD大家系,导致孤立性肾小管间质性肾病,符合KDIGO标准时应归类为ADTKD-JAG1。

研究设计与样本

  • 研究纳入203个ADTKD家系,以及来自 Genomics England 100,000 Genomes Project 的未知病因散发肾病和CKD5期病例。
  • 对携带JAG1致病变异患者的肾脏和/或尿路上皮细胞系进行免疫标记、Western blotting、靶向RNA-seq和定量RT-PCR研究,并检测内质网应激标志BiP表达。

主要发现

  • 在三个未确诊ADTKD大家系中鉴定出JAG1致病或可能致病变异,散发病例中亦发现额外罕见变异。
  • 两个家系中第四或第五代一名婴儿进一步确诊Alagille综合征,但23例成年孤立性肾衰竭患者(有肾活检者示肾小管间质性肾炎)均无肝、胆管、心脏、眼或骨骼明显异常。
  • JAG1表达研究和内质网应激分析提示,尽管JAG1突变RNA表达明显,肾小管间质病变并非由异常蛋白细胞毒性所致,而是由于单倍剂量不足和功能丧失。

关键数值与推荐

  • 根据KDIGO指南,当JAG1变异导致孤立性慢性肾脏病且符合ADTKD标准时,应分类为ADTKD-JAG1。
  • 尽管筛查UMOD、MUC1、REN、HNF1B和SEC61A1,仍有25%至50%的家系无分子诊断。

临床怎么用

  • 对临床符合ADTKD但常见基因筛查阴性的家系,应考虑JAG1基因检测。
  • JAG1变异携带者若表现为孤立性慢性肾脏病且符合ADTKD标准,可诊断为ADTKD-JAG1。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Autosomal dominant tubulointerstitial kidney disease (ADTKD) is a common monogenic kidney disease leading to kidney failure usually during mid adulthood. It is due to pathogenic variants in at least five genes. However, despite thorough screening of UMOD, MUC1, REN, HNF1B and SEC61A1, 25 to 50% of families remain without molecular diagnosis. METHODS: Here, we investigated a cohort of 203 families with ADTK, as well as sporadic cases of kidney disease of unknown etiology and cases of chronic kidney disease stage 5 from the Genomics England 100,000 Genomes Project. Expression of JAG1 in kidney and/or urinary epithelial cell (UREC) lines from patients carrying a pathogenic JAG1 variant associated with isolated ADTKD was studied using immunolabelling, Western blotting, targeted RNA-seq and quantitative RT-PCR. Endoplasmic reticulum (ER) stress was tested by analyzing ER protein BiP expression levels in URECs. RESULTS: A pathogenic or likely pathogenic variant in JAG1, the gene associated with Alagille syndrome, was identified in three large families with unsolved ADTKD, and additional rare variants were identified in sporadic cases. In two of the families, the diagnosis of Alagille syndrome was further established in one infant in the fourth or fifth generation; however, none of the 23 adult patients affected with isolated kidney failure (and tubulointerstitial nephritis in individuals with available kidney biopsy) had overt sign of liver, bile duct, heart, eye, or skeletal defect. JAG1 expression studies as well as ER stress analysis suggests that, despite a noteworthy expression of the JAG1-mutated RNAs, the tubulointerstitial renal disease was not due to cell toxicity of an abnormal protein, but rather to haploinsufficiency and loss of function. CONCLUSIONS: JAG1 pathogenic variants can be associated with isolated tubulointerstitial nephropathy which, according to the KDIGO guidelines, should be classified as ADTKD-JAG1 when JAG1 variants lead to isolated chronic kidney disease that fulfills the criteria for ADTKD.

来源:Kidney Int,查看原文。版权归原作者所有。

引用

  1. Menguy L, Hudier L, Zaidan M, et al. Mono-allelic pathogenic variants in JAG1 cause autosomal dominant tubulo-interstitial kidney disease (ADTKD-JAG1). Kidney Int. 2025. PMID: 41061854. doi:10.1016/j.kint.2025.08.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。